integratedmedicines.co.uk
Background
http://integratedmedicines.co.uk/background.html
IML; Maximising the impact of patient stratification for clinical and economic benefit. We aim to be the expert partner of choice to mediate, value, and manage strategic relationships and deals between the world’s top pharmaceutical developers, most innovative diagnostics companies and highly trusted regulatory agencies. A requirement for a companion diagnostic test adds further complexity to an already challenging R&D, regulatory and reimbursement landscape. IML can address these new areas and help ...
integratedmedicines.co.uk
Our Products & Services
http://integratedmedicines.co.uk/services.html
Our Products and Services. Products: Integrated Medicines Ltd (IML) seeks to impact three opportunities:. A) the association of an existing diagnostic test with a medicine that is. Currently in or nearing the market place;. B) the production of a diagnostic test manufactured exclusively for the. Purpose of aiding the launch and marketing of a late-stage medicine; and. C) the development of novel tests, from identification and clinical validation. Early-stage medicines development programmes. Diagnostic t...
integratedmedicines.co.uk
More IML Related News
http://integratedmedicines.co.uk/news.html
More IML Related News. Please use the links below to view each news item. IML’s sepsis SBRI contract progress update. Sepsis lives can be saved says Health Service Ombudsman. IML in (the other) Cambridge. IML at the Sachs Associates’ Annual Biotech in Europe Investor Forum. Dates for your diary. Stratification of Neurodegenerative Diseases More Funding Available. Stratified medicines in the news. Sepsis lives can be saved". A New Face in IML. Sepsis and Health Economics Modelling. IML Out and About.
integratedmedicines.co.uk
News
http://integratedmedicines.co.uk/news_03.03.15_03.html
UK Invests in Precision Medicine". As part of the UK’s commitment to stratified medicine, the Government’s innovation agency, Innovate UK is creating a new Catapult Centre in Precision Medicine. Prof. Richard Barker, chairman of South London Academic Health Science Network, and founding Director of the Centre for the Advancement of Sustainable Medical Innovation, has been announced as the new chairman of the Catapult, set to open later this year. For more information, click here. Integrated Medicines Ltd,.
integratedmedicines.co.uk
Enquiries
http://integratedmedicines.co.uk/enquiries.html
Please fill in the form below:. Your message has been sent. Alternatively, you can email us by selecting the suitable address below:. General Enquiries: enquiries@integratedmedicines.co.uk. Integrated Medicines Ltd,. Integrated Medicines Ltd 2013.
integratedmedicines.co.uk
Management Team
http://integratedmedicines.co.uk/management.html
IML is managed by a Board of Directors, consisting of the two founding directors. Blair and Bacarese-Hamilton) and two non-executive directors (Lowe and Crisanti). IML also has an advisory group of seven business people, strategists and scientists. Please click on the photos below to find out more details on the current personnel. Edward D Blair, PhD, MBA. Dr Blair is a molecular biologist/ biochemist with 15 years experience in the pharmaceutical industry. Andrea Crisanti MD, PhD. Christopher R Lowe, PhD.
integratedmedicines.co.uk
Welcome to Integrated Medicines Ltd
http://integratedmedicines.co.uk/index.html
Maximising the impact of patient stratification for clinical and economic benefit. IML Successfully Completes SBRI Sepsis Contract. IML's three year project to develop an economic model for the impact of point of care testing for sepsis has successfully completed. ABPI Report Finds Support for Stratified Medicines Approach. UK Invests in Precision Medicine. Obama launches $215m Stratified Medicine Initiative. IML is committed to the commercialisation of stratified medicines for optimal clinical and econo...
integratedmedicines.co.uk
News
http://integratedmedicines.co.uk/news_03.03.15_01.html
IML Successfully Completes SBRI Sepsis Contract. IML is committed to the commercialisation of stratified medicines for optimal clinical and economic benefit. We aim to be the trusted partner of choice to broker, value, and manage relationships and deals between the world’s top pharmaceutical developers, most innovative diagnostics companies and highly trusted regulatory agencies. Integrated Medicines Ltd,. Integrated Medicines Ltd 2013.
integratedmedicines.co.uk
Links & Documents
http://integratedmedicines.co.uk/links.html
Please use the links below to download each document. World Companion Diagnostics Summit - Pre-Conference Workshop. PDF, 2.1 MB). White paper - Sustaining development of stratified medicines in the UK healthcare system: a commentary. PDF, 741 KB). Stratified Medicines Workshop Report. WORD, 884 KB). E Blair In vitro diagnostics, June 2010. PDF, 2.5 MB). E Blair Future Med paper March 2010. PDF, 1.5 MB). Personalized Medicine (2010) 7(2), 143 161 hosted with permission of Future Medicine Ltd). PDF, 512 KB).